Kynam Capital Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $124M | Sell |
|
|||||
|
2025
Q1 | $118M | Buy |
|
|||||
|
2024
Q4 | $128M | Buy |
|
|||||
|
2024
Q3 | $118M | Buy |
|
|||||
|
2024
Q2 | $125M | Buy |
|
|||||
|
2024
Q1 | $122M | Sell |
|
|||||
|
2023
Q4 | $119M | Sell |
|
|||||
|
2023
Q3 | $88.1M | Buy |
|
|||||
|
2023
Q2 | $88.2M | Buy |
|
|||||
|
2023
Q1 | $50.7M | Sell |
|
|||||
|
2022
Q4 | $71.6M | Buy |
|
|||||
|
2022
Q3 | $45M | Buy |
|
|||||
|
2022
Q2 | $30.5M | Buy |
|
|||||
|
2022
Q1 | $25.6M | Buy |
|
|||||
|
2021
Q4 | $8.76M | Buy |
|